SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 413 filers reported holding SAREPTA THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is 0.85 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,471,273 | -33.7% | 20,517 | -37.5% | 0.00% | -33.3% |
| Q2 2023 | $3,727,806 | -33.7% | 32,847 | -19.5% | 0.01% | -33.3% |
| Q1 2023 | $5,620,983 | -3.6% | 40,782 | -9.3% | 0.01% | -10.0% |
| Q4 2022 | $5,828,120 | +28.1% | 44,977 | +9.3% | 0.01% | +25.0% |
| Q3 2022 | $4,548,000 | +1518.5% | 41,146 | +996.3% | 0.01% | – |
| Q2 2022 | $281,000 | -75.6% | 3,753 | -44.4% | 0.00% | -100.0% |
| Q4 2020 | $1,152,000 | -15.9% | 6,755 | -30.7% | 0.00% | -33.3% |
| Q3 2020 | $1,369,000 | -42.2% | 9,751 | -34.0% | 0.00% | -50.0% |
| Q2 2020 | $2,368,000 | +725.1% | 14,769 | +512.3% | 0.01% | +500.0% |
| Q1 2019 | $287,000 | -36.1% | 2,412 | -41.4% | 0.00% | 0.0% |
| Q4 2018 | $449,000 | -21.8% | 4,115 | +15.8% | 0.00% | 0.0% |
| Q3 2018 | $574,000 | – | 3,555 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Casdin Capital, LLC | 1,010,330 | $122,472,203 | 13.56% |
| Finepoint Capital LP | 145,357 | $17,620,176 | 8.78% |
| Avoro Capital Advisors LLC | 4,025,000 | $487,910,500 | 7.61% |
| Saturn V Capital Management LP | 118,401 | $14,352,569 | 6.01% |
| Ghost Tree Capital, LLC | 150,000 | $18,183,000 | 5.98% |
| Ikarian Capital, LLC | 3,673 | $44,524,106 | 5.36% |
| ACUTA CAPITAL PARTNERS, LLC | 550 | $7,580,650 | 5.08% |
| Eagle Health Investments LP | 174,212 | $21,117,979 | 4.65% |
| Boxer Capital, LLC | 600,000 | $72,732,000 | 3.87% |
| GREAT POINT PARTNERS LLC | 165,200 | $20,025,544 | 3.65% |